Authors

The Pharmacy Model Is Changing

Embracing artificial intelligence and other tools will be necessary to push the field forward.

The Evolving Fellowship Application Process

The process provides an opportunity for personal and professional growth.

Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases

Optimizing Infusion Chair Time for Oncology Trials: Follow-Up Study

This study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.

Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market

Second-line and later treatment options for synovial sarcoma are limited. Afamitresgene autoleucel is the first FDA-approved T-cell receptor therapy, demonstrating long-lasting responses and tolerable adverse effects in pretreated patients.

Updated European MASLD Guidelines Review Prevention, Screening, and Treatments

Patients should be supported by a multidisciplinary team, frequent evaluations, and behavioral therapy for optimal care.

The Financial Vital Sign Every Pharmacist Should Track

Tracking your net worth monthly can shift your financial mindset and build lasting wealth.

Conclusions

In the final segment, the panelists bring together the major insights from across the series, highlighting the most clinically meaningful data from monarchE, NATALEE, and VIKTORIA-1 and what these findings mean for the evolving role of CDK4/6 inhibitors in both early-stage and metastatic HR+ breast cancer.

DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer Chemotherapy

Navigating Pediatric Atopic Dermatitis: Insights Into Treatment, Challenges, and Care Considerations

Atopic dermatitis significantly impacts quality of life, and requires personalized management through trigger identification, skin barrier maintenance, and a range of topical, oral, and biologic therapies to reduce symptoms and prevent flare-ups.

HOPA 2025: Insights Into Post-Transplant Cyclophosphamide Use for Graft-Versus-Host Disease Prevention

Lauren Dietz, PharmD, highlighted the role of oncology pharmacists in guiding prophylaxis decisions to optimize transplant outcomes.

Essential Oils: A Pharmacist Guide for Alternative Pain Management

With Growing Patient Interest in Natural Remedies, Pharmacists Must Understand the Science, Safety, and Limitations of Essential Oils

HOPA Fellow Reflects on Mentorship, Leadership, and the Future of Oncology Pharmacy

Alexandra Wolff, PharmD, BCOP, FHOPA, was awarded a fellow of HOPA at the 2025 annual meeting.

Neuriva: A Closer Look at the Efficacy and Safety of this Popular Supplement

Hypertension: A Silent Killer Requiring Novel Therapies

Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.

Half of Pharmacy Technicians Feel Fulfilled in Their Current Role

The Connecticut Society of Health-System Pharmacists Technician Committee survey explores the perception of career growth opportunities and challenges.

Five Steps to Ensure Accurate 340B Program Data

Hospitals and health systems proactively monitor and manage data accuracy with third-party administrators to maintain 340B program compliance and maximize benefits for vulnerable patient populations.

Preparing for the Medicare Transaction Facilitator

Breaking Down Barriers to Care and Transforming Pharmacy Professionals’ Mental Health

Pharmacy professionals deserve the right to pursue mental health care without fear of losing their jobs. The Wellbeing First Champion Challenge is helping change this.

Respiratory Syncytial Virus in Older Adults: Research Insights and Recommendations

Although RSV has long been associated with infants and young children, research demonstrates that it is also a significant health risk for adults over the age of 60.

Weight Loss Drugs On the Horizon: What Pharmacists Should Know

Expanding Roles for Pharmacy Technicians in Ambulatory Oncology

Jessica Davis, PharmD, BCOP highlights the role of pharmacy technicians in ambulatory oncology clinic settings.

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.

Neuriva: A Closer Look at the Efficacy and Safety of this Popular Supplement

US Supreme Court Undercuts Long-Standing Judicial Deference to Administrative Agencies

Ruling potentially affects federal ability to regulate pharmacy.

Striking the Balance: Evidence-Based versus Defensive Medicine

Pharmacy Technicians as Non-Pharmacist Preceptors for a Sterile Compounding Rotation

Recognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.

Updates in Cancer Prevention and Screening for 2025: A Pharmacist Primer

Pharmacists play a vital role in cancer prevention and early detection by educating patients on risk factors, counseling on screening guidelines, and promoting adherence to evidence-based recommendations for common cancers, such as breast, cervical, colorectal, lung, prostate, and skin cancer.

Tar-200 Plus Anti–PD-1 Therapy Shows Promising Neoadjuvant Activity in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

Andrea Necchi, MD, shared SunRISe-4 primary results demonstrating higher pathologic response and relapse-free survival rates with TAR-200 plus sacituzumab compared with checkpoint inhibitor monotherapy, with no new safety signals observed.

Bispecifics, CAR T Cells Among Most Exciting Recent Advances in Hematologic Malignancies

Expert notes significant advances in the treatment of multiple myeloma, large B cell lymphomas, and acute myeloid leukemia, during a presentation at HOPA 2023 Annual Conference.